| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A localised threat to an excellent antimalarial drug
|
Gbotosho, Grace Olusola
|
|
2015
|
15 |
6 |
p. 623-624
2 p.
|
artikel
|
| 2 |
A novel outbreak enterovirus D68 strain associated with acute flaccid myelitis cases in the USA (2012–14): a retrospective cohort study
|
Greninger, Alexander L
|
|
2015
|
15 |
6 |
p. 671-682
12 p.
|
artikel
|
| 3 |
A pill a day keeps HCV away
|
Gentile, Ivan
|
|
2015
|
15 |
6 |
p. 616-617
2 p.
|
artikel
|
| 4 |
Approaches to demonstration of Ebola virus vaccine efficacy
|
Krause, Philip R
|
|
2015
|
15 |
6 |
p. 627-629
3 p.
|
artikel
|
| 5 |
Are adaptive randomised trials or non-randomised studies the best way to address the Ebola outbreak in west Africa?
|
Lanini, Simone
|
|
2015
|
15 |
6 |
p. 738-745
8 p.
|
artikel
|
| 6 |
Bilateral conjunctival swelling after dental extraction
|
Karssemakers, Luc H E
|
|
2015
|
15 |
6 |
p. 746-
1 p.
|
artikel
|
| 7 |
Can sequence data predict enterovirus D68 infection outcome?
|
Norder, Heléne
|
|
2015
|
15 |
6 |
p. 620-621
2 p.
|
artikel
|
| 8 |
Corrections
|
|
|
2015
|
15 |
6 |
p. 629-
1 p.
|
artikel
|
| 9 |
Corrections
|
|
|
2015
|
15 |
6 |
p. 629-
1 p.
|
artikel
|
| 10 |
Corrections
|
|
|
2015
|
15 |
6 |
p. 629-
1 p.
|
artikel
|
| 11 |
Corrections
|
|
|
2015
|
15 |
6 |
p. 629-
1 p.
|
artikel
|
| 12 |
Dihydroartemisinin-piperaquine failure associated with a triple mutant including kelch13 C580Y in Cambodia: an observational cohort study
|
Spring, Michele D
|
|
2015
|
15 |
6 |
p. 683-691
9 p.
|
artikel
|
| 13 |
Ebola vaccine trials: a race against the clock
|
Chowell, Gerardo
|
|
2015
|
15 |
6 |
p. 624-626
3 p.
|
artikel
|
| 14 |
Effect of climate change on vector-borne disease risk in the UK
|
Medlock, Jolyon M
|
|
2015
|
15 |
6 |
p. 721-730
10 p.
|
artikel
|
| 15 |
Effects of oseltamivir treatment of index patients with influenza on secondary household illness in an urban setting in Bangladesh: secondary analysis of a randomised, placebo-controlled trial
|
Fry, Alicia M
|
|
2015
|
15 |
6 |
p. 654-662
9 p.
|
artikel
|
| 16 |
Ethics of HIV research in children
|
Rossouw, Theresa M
|
|
2015
|
15 |
6 |
p. 634-635
2 p.
|
artikel
|
| 17 |
From the big three to the big four
|
Chen, Ding-Shinn
|
|
2015
|
15 |
6 |
p. 626-627
2 p.
|
artikel
|
| 18 |
Global extent of chloroquine-resistant Plasmodium vivax
|
Wang, Wei
|
|
2015
|
15 |
6 |
p. 630-
1 p.
|
artikel
|
| 19 |
Global extent of chloroquine-resistant Plasmodium vivax
|
Brendish, Nathan J
|
|
2015
|
15 |
6 |
p. 630-
1 p.
|
artikel
|
| 20 |
Global extent of chloroquine-resistant Plasmodium vivax – Authors' reply
|
Price, Ric N
|
|
2015
|
15 |
6 |
p. 630-631
2 p.
|
artikel
|
| 21 |
Hepatitis A outbreaks
|
Pahil, Sapna
|
|
2015
|
15 |
6 |
p. 634-
1 p.
|
artikel
|
| 22 |
Hepatitis A outbreaks
|
Severi, Ettore
|
|
2015
|
15 |
6 |
p. 632-634
3 p.
|
artikel
|
| 23 |
Highlights from the 25th ECCMID
|
Bosurgi, Raffaella
|
|
2015
|
15 |
6 |
p. 639-640
2 p.
|
artikel
|
| 24 |
HIV/AIDS registration in Pakistan
|
Qureshi, Muhammad Asif
|
|
2015
|
15 |
6 |
p. 635-636
2 p.
|
artikel
|
| 25 |
Human infection with a novel tick-borne Anaplasma species in China: a surveillance study
|
Li, Hao
|
|
2015
|
15 |
6 |
p. 663-670
8 p.
|
artikel
|
| 26 |
India's budget reduction and AIDS initiatives
|
Agoramoorthy, Govindasamy
|
|
2015
|
15 |
6 |
p. 636-
1 p.
|
artikel
|
| 27 |
India tackles vaccine preventable diseases
|
Bagcchi, Sanjeet
|
|
2015
|
15 |
6 |
p. 637-638
2 p.
|
artikel
|
| 28 |
Infectious causes of stroke
|
Hsu, Ching-Sheng
|
|
2015
|
15 |
6 |
p. 631-632
2 p.
|
artikel
|
| 29 |
Infectious causes of stroke
|
Garkowski, Adam
|
|
2015
|
15 |
6 |
p. 632-
1 p.
|
artikel
|
| 30 |
Infectious disease surveillance update
|
Zwizwai, Ruth
|
|
2015
|
15 |
6 |
p. 642-
1 p.
|
artikel
|
| 31 |
Koch, consumption, and Conan Doyle
|
Ali, Mohsin
|
|
2015
|
15 |
6 |
p. 644-
1 p.
|
artikel
|
| 32 |
Ledipasvir and sofosbuvir fixed-dose combination with and without ribavirin for 12 weeks in treatment-naive and previously treated Japanese patients with genotype 1 hepatitis C: an open-label, randomised, phase 3 trial
|
Mizokami, Masashi
|
|
2015
|
15 |
6 |
p. 645-653
9 p.
|
artikel
|
| 33 |
Malaria resistance to non-artemisinin partner drugs: how to reACT
|
van Schalkwyk, Donelly A
|
|
2015
|
15 |
6 |
p. 621-623
3 p.
|
artikel
|
| 34 |
Of goats and men: rethinking anaplasmoses as zoonotic infections
|
Beyer, Andrea R
|
|
2015
|
15 |
6 |
p. 619-620
2 p.
|
artikel
|
| 35 |
Oseltamivir reduces clinical illness in households in Bangladesh
|
Barr, Ian G
|
|
2015
|
15 |
6 |
p. 617-619
3 p.
|
artikel
|
| 36 |
Re-emergence of neglected tropical diseases in Venezuela
|
Burki, Talha
|
|
2015
|
15 |
6 |
p. 641-642
2 p.
|
artikel
|
| 37 |
Research brief
|
Bradbury, Jane
|
|
2015
|
15 |
6 |
p. 643-
1 p.
|
artikel
|
| 38 |
Severe liver fibrosis caused by Schistosoma mansoni: management and treatment with a transjugular intrahepatic portosystemic shunt
|
Richter, Joachim
|
|
2015
|
15 |
6 |
p. 731-737
7 p.
|
artikel
|
| 39 |
Statistical power and validity of Ebola vaccine trials in Sierra Leone: a simulation study of trial design and analysis
|
Bellan, Steven E
|
|
2015
|
15 |
6 |
p. 703-710
8 p.
|
artikel
|
| 40 |
The Ebola endgame, and what comes after
|
The Lancet Infectious Diseases,
|
|
2015
|
15 |
6 |
p. 615-
1 p.
|
artikel
|
| 41 |
The effect of dose on the antimalarial efficacy of artemether–lumefantrine: a systematic review and pooled analysis of individual patient data
|
|
|
2015
|
15 |
6 |
p. 692-702
11 p.
|
artikel
|
| 42 |
Towards early inclusion of children in tuberculosis drugs trials: a consensus statement
|
Nachman, Sharon
|
|
2015
|
15 |
6 |
p. 711-720
10 p.
|
artikel
|
Tijdschrift beschrijving